Company intelligence / Profile preview

SMi Systems

Edinburgh, Scotland, United Kingdomsmisupplychain.com ↗

Ownership: Private
Development stage: Other

Overview

SMi Systems has developed an automated biomedical research platform that combines proprietary computational modeling with super-resolution imaging. This allows unprecedented quantification of single molecules in high-throughput formats. The system can screen thousands of candidates per hour using minimal sample volumes and supports applications in drug discovery, lead optimization, diagnostics development, and basic research—especially for challenging targets like membrane proteins.

Modalities: Small moleculeMonoclonal antibodyVaccine
Industry: Non-Drug Biotech

Beyond the preview

Go deeper on SMi Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMi Systems.

Explore the full profile